Correction: Althenayyan et al. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. J. Pers. Med. 2023, 13, 135 | Synapse
January 25, 2026Open Access
Correction: Althenayyan et al. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. J. Pers. Med. 2023, 13, 135
Key Points
The aim is to explore alternative splicing of MUC4 and ADAM12 as potential biomarkers for metastatic colorectal cancer.
Correction of errors in previously published figures
Analysis of alternatively spliced isoforms
Identification of biomarkers for colorectal cancer
Revised data on MUC4 and ADAM12 isoforms
Enhanced understanding of biomarkers related to cancer metastasis